Kiran Shekar
Papers
1
Total Citations
57
H-Index
1
About
Kiran Shekar is a leading critical care researcher whose work focuses on the pharmacokinetics and pharmacodynamics of drugs in critically ill patients, particularly those on extracorporeal membrane oxygenation (ECMO). His major contributions include pioneering studies on how ECMO circuits alter drug metabolism and clearance, directly impacting dosing strategies for sedatives, analgesics, and antibiotics in intensive care. One of his most cited works, a 2012 paper detailing a high-throughput LC–MS/MS assay for quantifying morphine, fentanyl, midazolam, and their metabolites, has garnered 57 citations and remains a foundational method for therapeutic drug monitoring in complex ICU settings. Shekar’s research has been instrumental in bridging the gap between pharmacology and critical care, leading to safer, more effective medication regimens for patients on life support. His work is widely recognized for its translational impact, helping clinicians avoid under- or over-dosing in vulnerable populations. With a strong publication record and ongoing collaborations, Shekar continues to shape evidence-based practices in ECMO pharmacology.
Research Focus
Key Achievements
Top Papers
- 1